KFAS
WST icon

Keating Financial Advisory Services’s West Pharmaceutical WST Stock Holding History

Keating Financial Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1K Buy
67
+26
+63% +$7.95K ﹤0.01% 912
2026
Q1 		$10.3K Buy
41
+8
+24% +$1.99K ﹤0.01% 1117
2025
Q4 		$9.08K Buy
+33
New +$9.03K ﹤0.01% 1126

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Keating Financial Advisory Services's WST Position: Q2 2026 in Review

Keating Financial Advisory Services increased its West Pharmaceutical (WST) stake by 63% in Q2 2026, buying an estimated $7.95K and bringing the position to 67 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

Keating Financial Advisory Services first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Keating Financial Advisory Services held 67 shares of West Pharmaceutical worth $24.1K as of Q2 2026.
  • Keating Financial Advisory Services bought 26 West Pharmaceutical shares in Q2 2026, an estimated $7.95K.
  • West Pharmaceutical made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #912 holding.
  • Keating Financial Advisory Services first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.